MannKind Corp (NASDAQ:MNKD)

1.32
Delayed Data
As of Sep 20
 0.00 / 0.00%
Today’s Change
0.94
Today|||52-Week Range
2.34
+24.53%
Year-to-Date

Today’s Trading

Previous close1.32
Today’s open1.32
Day’s range1.26 - 1.34
Volume3,643,686
Average volume (3 months)2,266,426
Market cap$259.8M
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+46.60%
Earnings growth (this year)+48.75%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+137.20%
P/E ratioNM
Price/Sales5.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EVLOEvelo Biosciences In...-0.29-3.55%
INOInovio Pharmaceutica...+0.05+2.06%
CNCEConcert Pharmaceutic...-0.08-0.74%
STROSutro Biopharma Inc-0.10-0.93%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 5, 2019
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$27.9M
Annual profit (last year)-$87.0M
Net profit margin-312.20%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael E. Castagna
CFO &
Principal Accounting Officer
Steven Binder
Corporate headquarters
Westlake Village, California

Forecasts